- likes
- 320
- comments
- 9
Post
Yesterday the Department of Health and Human Services moved to allow compounding of six peptides while formal rulemaking is underway, giving people a real alternative to the dangerous gray market so many are already using, often without a clinician involved or knowing what’s actually in the product. This draft interim policy helps create a safer, regulated path with the oversight, quality standards and transparency we’ve been advocating for. Read more from Andrew Dudum our co-founder and CEO on what this means for how we’re planning to offer access to Peptides+, our upcoming specialty: https://lnkd.in/g_DWEbyN https://lnkd.in/g3uUZkwF Important disclaimers here: https://lnkd.in/gk8VeEDD